BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 17074322)

  • 21. A mild ovarian stimulation strategy in women with poor ovarian reserve undergoing IVF: a multicenter randomized non-inferiority trial.
    Youssef MA; van Wely M; Al-Inany H; Madani T; Jahangiri N; Khodabakhshi S; Alhalabi M; Akhondi M; Ansaripour S; Tokhmechy R; Zarandi L; Rizk A; El-Mohamedy M; Shaeer E; Khattab M; Mochtar MH; van der Veen F
    Hum Reprod; 2017 Jan; 32(1):112-118. PubMed ID: 27836979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone agonist/antagonist conversion with estrogen priming in low responders with prior in vitro fertilization failure.
    Fisch JD; Keskintepe L; Sher G
    Fertil Steril; 2008 Feb; 89(2):342-7. PubMed ID: 17562336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles.
    Dovey S; McIntyre K; Jacobson D; Catov J; Wakim A
    Fertil Steril; 2011 Sep; 96(3):585-9. PubMed ID: 21774931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of treatment with ovarian stimulation and intrauterine insemination in women with unilateral tubal occlusion diagnosed by hysterosalpingography.
    Farhi J; Ben-Haroush A; Lande Y; Fisch B
    Fertil Steril; 2007 Aug; 88(2):396-400. PubMed ID: 17445812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B infection and outcomes of in vitro fertilization and embryo transfer treatment.
    Lam PM; Suen SH; Lao TT; Cheung LP; Leung TY; Haines C
    Fertil Steril; 2010 Feb; 93(2):480-5. PubMed ID: 19324342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome of in vitro fertilization/intracytoplasmic sperm injection after laparoscopic cystectomy for endometriomas.
    Esinler I; Bozdag G; Aybar F; Bayar U; Yarali H
    Fertil Steril; 2006 Jun; 85(6):1730-5. PubMed ID: 16690058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pioglitazone on ovarian stromal blood flow, ovarian stimulation, and in vitro fertilization outcome in patients with polycystic ovary syndrome.
    Kim CH; Jeon GH; Kim SR; Kim SH; Chae HD; Kang BM
    Fertil Steril; 2010 Jun; 94(1):236-41. PubMed ID: 19324344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with piroxicam before embryo transfer increases the pregnancy rate after in vitro fertilization and embryo transfer.
    Moon HS; Park SH; Lee JO; Kim KS; Joo BS
    Fertil Steril; 2004 Oct; 82(4):816-20. PubMed ID: 15482753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estradiol production during controlled ovarian hyperstimulation correlates with treatment outcome in women undergoing in vitro fertilization-embryo transfer.
    Mitwally MF; Bhakoo HS; Crickard K; Sullivan MW; Batt RE; Yeh J
    Fertil Steril; 2006 Sep; 86(3):588-96. PubMed ID: 16814289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization.
    Morgia F; Sbracia M; Schimberni M; Giallonardo A; Piscitelli C; Giannini P; Aragona C
    Fertil Steril; 2004 Jun; 81(6):1542-7. PubMed ID: 15193474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients.
    Hompes PG; Broekmans FJ; Hoozemans DA; Schats R;
    Fertil Steril; 2008 Jun; 89(6):1685-93. PubMed ID: 17681325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of GnRH-antagonist to IVF-ET for patients with poor ovarian response].
    Wang B; Sun HX; Hu YL; Chen H; Zhang NY
    Zhonghua Nan Ke Xue; 2008 May; 14(5):423-6. PubMed ID: 18572861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of coasting on cycle outcome during in vitro fertilization/intracytoplasmic sperm injection cycles in hyper-responders.
    Kovács P; Mátyás S; Kaali SG
    Fertil Steril; 2006 Apr; 85(4):913-7. PubMed ID: 16580374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
    Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
    Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Egg production predicts a doubling of in vitro fertilization pregnancy rates even within defined age and ovarian reserve categories.
    Yih MC; Spandorfer SD; Rosenwaks Z
    Fertil Steril; 2005 Jan; 83(1):24-9. PubMed ID: 15652882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
    Heijnen EM; Eijkemans MJ; Hughes EG; Laven JS; Macklon NS; Fauser BC
    Hum Reprod Update; 2006; 12(1):13-21. PubMed ID: 16123051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
    Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M
    Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of starting ovarian stimulation on day 2 versus day 15 of the menstrual cycle in the same oocyte donor and pregnancy rates among the corresponding recipients of vitrified oocytes.
    Martínez F; Clua E; Devesa M; Rodríguez I; Arroyo G; González C; Solé M; Tur R; Coroleu B; Barri PN
    Fertil Steril; 2014 Nov; 102(5):1307-11. PubMed ID: 25154677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of estradiol supplementation during the luteal phase improves the pregnancy rate in women undergoing in vitro fertilization-embryo transfer cycles.
    Lukaszuk K; Liss J; Lukaszuk M; Maj B
    Fertil Steril; 2005 May; 83(5):1372-6. PubMed ID: 15866571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.